Blood Glucose Monitoring Devices Market 2021-2025: Smart Watch-based  Apps will Boost Market Growth

The blood glucose monitoring devices market share is expected to grow by USD 5.84 billion, accelerating at a CAGR of 8.16% during the forecast period. Technological advances in BGM devices will offer immense growth opportunities to market vendors. The growth trajectory of the market is traced through a detailed analysis of the prevalent market forces, trends, and drivers along with competitive benchmarking

Blood Glucose Monitoring Devices Market Analysis 2021-2025: View the Free Sample Analysis Report

Blood Glucose Monitoring Devices Market: Emerging Trends to Impact Market Growth

Smart watch-based apps are likely to emerge as the major blood glucose monitoring devices market trends that positively impact market growth. Technavio's blood glucose monitoring devices market report provides a detailed analysis of all the trends that are likely to influence the growth of individual segments within the market as well as the overall market in focus. This analysis will enable clients to assess their play in the market and plan for growth opportunities.

Blood Glucose Monitoring Devices Market: Vendor Analysis

The market is fragmented due to the presence of several players. The growth of the players depends on several factors such as market conditions, government support, and industry development. To survive and succeed in such an intensely competitive market, players must distinguish their product and service offerings through clear and unique value propositions.

Abbott Laboratories, Agamatrix Inc., ARKRAY Inc., Ascensia Diabetes Care Holdings AG, Dexcom Inc., F. Hoffmann La Roche Ltd., Johnson and Johnson Inc., Medtronic Plc, Terumo Europe NV, and Trivida Health Inc. are some of the major blood glucose monitoring devices market vendors.

To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their position in the slow-growing segments.

Technavio custom reports provide market insights at the global and regional levels along with pipeline analysis of new product launches. It also provides a peek into the latest R&D along with impact analysis of government regulations. Download the Free PDF Sample Report

The report provides insights into the following FAQs:

1. What is the market CAGR?
   The market is accelerating at a CAGR of 8.16%.
    
2. What is the incremental growth of the market?
   The market is expected to grow by USD 5.84 billion.
    
3. What is a key factor driving this market?
   Technological advances in BGM devices will drive market growth over the forecast period.
    
4. What are the key regions covered in this market research report?
   North America, Europe, Asia, and ROW are the key regions featured in this research report.
    
5. Which is the leading geographic region for this market?
   43% growth will originate from North America.
    
6. Who are the leading market vendors?
   The leading vendors in this market are Abbott Laboratories, Agamatrix Inc., ARKRAY Inc., Ascensia Diabetes Care Holdings AG, Dexcom Inc., F. Hoffmann La Roche Ltd., Johnson and Johnson Inc., Medtronic Plc, Terumo Europe NV, and Trivida Health Inc.
    
7. What are the market segments covered in this report?
   The market is segmented by Product (SMBG, CGM, and Lancets) and Geography (North America, Europe, Asia, and ROW).